Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-09-02 19:54:51 ET · period of report 2026-08-31 · accession 0001960048-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-02 19:54 | 2026-08-31+ | PCVX | Cowan Elvia | SVP, CAO, Fin | F - Tax | $61.22 | -569 | 29.2K | -2% | -$34.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | F | D | 243 | $60.74 | 29,513 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. (F2) Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
| 2 | Common | Common Stock | 2026-09-02 | F | D | 326 | $61.58 | 29,187 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |